For Providers

Introducing the PrecisionPoint™ Transperineal Access System

Introducing the PrecisionPoint™

Transperineal

Access System

The PrecisionPoint™ Transperineal Access System (PPTAS) revolutionizes the methodology for obtaining prostate biopsies. This medical system takes full advantage of the transperineal path to more thoroughly sample all regions of the prostate including the anterior zone. Since the technique is free hand, the practitioner is not restricted to biopsy locations dictated by a grid configuration. The practitioner can freely maneuver the ultrasound probe to align the access needle to target the desired locations with certainty in a strategic and parallel direction.

The patented clamping mechanism allows the practitioner to use their existing BK ultrasound platform and cylindrical transrectal ultrasound transducer probe (0.7” – 0.85” BK #8658 or equivalent). Using a bi-plane linear ultrasound probe, one can adjust the position not only to probes of varying diameter, but also to any location along the shaft of the probe. An access needle press fits into the desired aperture of the sliding carriage allowing for a multitude of samples to be taken through a single puncture of the skin.

In addition, the PrecisionPoint™ Transperineal Access System (PPTAS) minimizes the potential for infection, since passage of the biopsy needle avoids the rectal wall contaminants entirely. For the patient, this means no bowel prep or need to pre-medicate with antibiotics. The PPTAS enables the practitioner to perform the biopsy under local anesthesia in a time sensitive fashion.

PrecisionPoint™
Transperineal Access System

Now FDA Cleared!

This detailed animation describes the advantages and the usage of this revolutionary system.

Click the arrow to watch. (duration is 4:27)

Results Using the Free-Hand Transperineal Approach

These data represent results from prostate biopsies performed under the following conditions:

  • Multi surgeon, single site

  • All free-hand transperineal technique

  • With/without PrecisionPoint™ Transperineal Access System

  • Performed under local or mild sedation

(Data current as of 14 July 2017.)

If you would like additional information please contact us.


Procedures Performed:

1033


Median Age of Patient:

years

67


Median PSA:

ng/dL

7.8


Mean Prostate Volume by US:

ml

46.6


Median Procedure Time / Room Time:

minutes

10 / 20


Median Number of Cores Per Procedure:

(L/R/B)

8/8/0


Total Cancer Positive:

percent

59.15


Significant Dx:

percent ≥ Gleason 7

62.8


Complications:

urine retention

1

infections

0


Procedure Videos

(These are scientific videos and may contain graphic content.)

Using PrecisionPoint™ With MRI Fusion (Presented at 2017 AUA)

Using PrecisionPoint™ with MRI Fusion (Short Version)

Using PrecisionPoint™ Under Local (2016 AUA Award Winner)

Freehand Transperineal Biopsy (2014 AUA Award Winner)

Using PrecisionPoint™ I